NVO
Novo Nordisk A/S
NVO offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
PYPL
PayPal Holdings, Inc.
PYPL has the edge over NVO overall, supported by stronger valuation and lower modeled downside.
NVO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
NVO's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
PYPL Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
PYPL's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like PYPL.
NVO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 10x | $40.65 | — |
| Cheap | 14x | $53.56 | +32% |
| Fair | 27x | $103 | +154% |
| Expensive | 39x | $152 | +273% |
Historical ranges are pointers, not guarantees.
NVO has the edge over PYPL in the historical PE scenario, which offers more potential upside but is not a forecast.
PYPL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 9.9x | $58.30 | — |
| Current | 11x | $58.30 | — |
| Cheap | 15x | $76.16 | +31% |
| Fair | 26x | $136 | +133% |
| Expensive | 67x | $351 | +503% |
Historical ranges are pointers, not guarantees.
PYPL's PE is in its cheap range at 11x. If earnings grow as analysts expect, today's price would be 9.9x next year's earnings.
NVO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect NVO's revenue to grow, but its profitability to weaken. However, they disagree widely on these estimates.
PYPL Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Improving | |
| Moderate | |
| High |
Analysts expect PYPL's earnings to grow and its profitability to improve, with its revenue holding steady.
NVO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.89 | +4.9% |
| Q1 2026 | $4.07 | +17% |
| Q4 2025 | $3.42 | +1.8% |
| Q3 2025 | $3.47 | +10% |
| Q2 2025 | $3.71 | +24% |
| Q1 2025 | $3.49 | +18% |
| Q4 2024 | $3.36 | +21% |
| Q3 2024 | $3.15 | +27% |
NVO has the edge over PYPL on earnings, with stronger typical year-over-year growth.
PYPL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.87 | +12% |
| Q3 2026 | $5.24 | +5.4% |
| Q2 2026 | $5.29 | +14% |
| Q1 2026 | $5.33 | +20% |
| Q4 2025 | $5.41 | +36% |
| Q3 2025 | $4.97 | +19% |
| Q2 2025 | $4.66 | +13% |
| Q1 2025 | $4.45 | +12% |
| Q4 2024 | $3.99 | +3.9% |
PYPL's earnings per share have climbed steadily: $5.24 over the past year, up 5.4% from the year before, and higher year over year for 14 quarters in a row.
NVO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $11.7B | +2.1% |
| Q1 2026 | $14.4B | +24% |
| Q4 2025 | $11.8B | -7.6% |
| Q3 2025 | $11.1B | +5.1% |
| Q2 2025 | $11.4B | +13% |
| Q1 2025 | $11.6B | +19% |
| Q4 2024 | $12.7B | +30% |
| Q3 2024 | $10.6B | +21% |
NVO's revenue is growing: $11.7B last quarter, up 2.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 34% | -9 points |
| Q1 2026 | 62% | +12 points |
| Q4 2025 | 40% | -2.8 points |
| Q3 2025 | 32% | -16 points |
| Q2 2025 | 44% | +5.4 points |
| Q1 2025 | 50% | +1 points |
| Q4 2024 | 43% | +2.2 points |
| Q3 2024 | 47% | +1.6 points |
NVO has the edge over PYPL on profitability, with a higher operating margin.
PYPL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $8.6B | +2% |
| Q2 2026 | $8.7B | +4.8% |
| Q1 2026 | $8.4B | +7.2% |
| Q4 2025 | $8.7B | +3.7% |
| Q3 2025 | $8.4B | +7.3% |
| Q2 2025 | $8.3B | +5.1% |
| Q1 2025 | $7.8B | +1.2% |
| Q4 2024 | $8.4B | +4.2% |
PYPL's revenue has grown year over year every quarter since late 2020: $8.6B last quarter, up 2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 16% | -1.7 points |
| Q2 2026 | 16% | -1.7 points |
| Q1 2026 | 18% | -1.8 points |
| Q4 2025 | 17% | +0.2 points |
| Q3 2025 | 18% | +0.3 points |
| Q2 2025 | 18% | +1.3 points |
| Q1 2025 | 20% | +4.5 points |
| Q4 2024 | 17% | -4.3 points |
PYPL's operating margin was 16% last quarter, down 1.7 points from the same quarter a year ago.
NVO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $6.3B | +73% |
| Q1 2026 | $1.8B | +20% |
| Q4 2025 | -$5.4B | -$4.7B |
| Q3 2025 | $4.6B | -2.1% |
| Q2 2025 | $3.6B | -34% |
| Q1 2025 | $1.5B | +89% |
| Q4 2024 | -$632.6M | +$390.5M |
| Q3 2024 | $4.7B | +3.3% |
NVO has the edge over PYPL on cash flow, with more consistent year-over-year improvement.
PYPL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.4B | -17% |
| Q2 2026 | $1.8B | +157% |
| Q1 2026 | $903M | -6.3% |
| Q4 2025 | $2.2B | 0% |
| Q3 2025 | $1.7B | +19% |
| Q2 2025 | $692M | -49% |
| Q1 2025 | $964M | -45% |
| Q4 2024 | $2.2B | -11% |
PYPL's free cash flow was $6.3B over the past year, up 13% from the year before. Free cash flow isn't a meaningful measure for financial services companies like PYPL.
NVO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -12.9M shares |
| 1 year | -0.2% | -11M shares |
| 3 years | -1.5% | -66.8M shares |
| 5 years | -3.8% | -177M shares |
| Available history | -6.5% | -311M shares |
NVO has 4.4B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $520M |
| Q1 2026 | $356.7M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $206.3M |
| Q4 2024 | $1.1B |
| Q3 2024 | $357.4M |
NVO spent $877M buying back its own shares over the past year, down 48% from the year before.
PYPL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.7% | -24M shares |
| 1 year | -11% | -102M shares |
| 3 years | -22% | -240M shares |
| 5 years | -28% | -329M shares |
| Available history | -28% | -329M shares |
PYPL has the edge over NVO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.5B |
| Q2 2026 | $1.6B |
| Q1 2026 | $1.5B |
| Q4 2025 | $1.5B |
| Q3 2025 | $1.5B |
| Q2 2025 | $1.6B |
| Q1 2025 | $1.5B |
| Q4 2024 | $1.3B |
PYPL spent $6.1B buying back its own shares over the past year, up 4% from the year before.
NVO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.7x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
| Q3 2024 | -0.0x | Very low |
NVO has the edge over PYPL on leverage, with a lower net debt burden relative to earnings.
PYPL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.9x | Very low |
| Q2 2026 | 0.7x | Very low |
| Q1 2026 | 0.4x | Very low |
| Q4 2025 | 0.3x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.6x | Very low |
| Q4 2024 | 0.5x | Very low |
PYPL's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like PYPL.
NVO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 27.0 | Neutral |
NVO's weekly RSI is 43 (neutral) and its Stochastic is 27 (neutral).
PYPL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.2 | Neutral |
| Stochastic | 61.9 | Neutral |
PYPL's weekly RSI is 58 (neutral) and its Stochastic is 62 (neutral).
NVO PE vs Healthcare Sector
| Metric | NVO | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 26x | 60% below |
| PE % | 6 | 29 | 23 pts below |
NVO has the edge over PYPL on valuation relative to its sector.
PYPL PE vs Financial Services Sector
| Metric | PYPL | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 15% below |
| PE % | 10 | 63 | 53 pts below |
PYPL is trading at 11x earnings, a 15% discount to the Financial Services sector's median of 13x.
NVO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.2 | 3.7% above |
| 20 week MA | $43.9 | 7.4% below |
| 50 week MA | $45.3 | 10% below |
| 100 week MA | $56.3 | 28% below |
| 200 week MA | $80.7 | 50% below |
NVO has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 50% below its 200-week average.
PYPL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $56.5 | 3.3% above |
| 20 week MA | $55.5 | 5% above |
| 50 week MA | $51.5 | 13% above |
| 100 week MA | $61.6 | 5.4% below |
| 200 week MA | $64.5 | 9.6% below |
PYPL has the edge over NVO on trend strength, trading above more of its moving averages.
NVO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.1 | $34.7 | +19% |
| 2021 | $34.7 | $54.2 | +56% |
| 2022 | $54.2 | $67.0 | +24% |
| 2023 | $67.0 | $103.5 | +54% |
| 2024 | $103.5 | $87.4 | -16% |
| 2025 | $87.4 | $52.4 | -40% |
| 2026 YTD | $52.4 | $40.7 | -22% |
NVO has finished higher in four of the last six years, two of them by more than 50%. It's down 22% so far in 2026.
PYPL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $109.4 | $238.6 | +118% |
| 2021 | $238.6 | $192.0 | -20% |
| 2022 | $192.0 | $69.0 | -64% |
| 2023 | $69.0 | $61.4 | -11% |
| 2024 | $61.4 | $86.9 | +41% |
| 2025 | $86.9 | $60.0 | -31% |
| 2026 YTD | $60.0 | $58.3 | -2.8% |
PYPL has the edge over NVO on returns for 2026, with the stronger performance.